9.4900
07-مايو-25 16:45:00
15 متأخرة بدقائق
الأسهم
+0.3800
+4.17%
نطاق اليوم
8.7700 - 9.7000
ISIN
N/A
المصدر
NASDAQ
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
31 مارس 2025 07:30:00 بحسب Nasdaq GlobeNewswire
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
07 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire